Table 1 Patient demographics between groups
Variable | CB (n = 130) | CA (n = 134) | p-value |
|---|---|---|---|
Age at onset (years) | 67.22 ± 5.33 | 67.43 ± 7.53 | 0.346a |
Histology, n (%) | 0.885b | ||
Squamous | 74(57) | 76(57) | |
Adenocarcinoma | 43(33) | 48(36) | |
Other | 13(10) | 10(7) | |
Disease presentation, n (%) | 0.501b | ||
Recurrent | 35(27) | 33(25) | |
Persistent | 27(21) | 25(19) | |
Stage IVB | 68(52) | 76(56) | |
Prior treatment, n (%) | 0.489b | ||
Radical surgery | 14(11) | 22(16) | |
Radical radiotherapy | 25(19) | 27(20) | |
Radiotherapy adjuvant | 34(26) | 30(22) | |
Radical chemoradiotherapy | 19(15) | 16(12) | |
Palliative radiotherapy | 27(21) | 23(17) | |
No prior treatment | 11(8) | 16(13) | |
Duration of treatment (mo) | 28.63 ± 7.15 | 28.35 ± 7.42 | 0.225a |
Performance status (ECOG), n (%) | 0.955b | ||
0 | 47(36) | 48(36) | |
1 | 83(64) | 86(64) | |
GOG performance status, n (%) | 0.970b | ||
0 | 42(32) | 43(32) | |
1 | 88(68) | 91(68) | |
Number of metastatic sites, n (%) | 0.234b | ||
3 | 33(25) | 27(20) | |
> 3 | 77(59) | 81(60) | |
unknown | 20(16) | 26(20) | |
Prior pelvic radiotherapy, n (%) | 0.889b | ||
Yes | 60(46) | 63(47) | |
No | 70(54) | 71(53) |